News
DSM delivers ‘very strong’ Q2 results
Royal DSM NV reported an increase in net profit due to an easy year-earlier comparison, re-stocking and cost cutting measures.
Highlights
- Q2 operating profit from continuing operations €246m (vs €85m in Q2 2009 and €194m in Q1 2010)
- Sales growth from continuing operations 28% compared to Q2 2009
- Excellent nutrition performance drives Life Sciences results
- Materials sciences continues profit improvement
- Cash flow from operating activities in Q2 €223m
- Interim dividend unchanged at €0.40 per ordinary share
- Based on current positive business environment, 2010 is expected to be a strong year for DSM.
Commenting on the results, Feike Sijbesma, chairman of the DSM managing board, said: “I’m delighted to report a very strong second quarter. Operating profit increased by more than 25% compared to the first quarter, and for the current business portfolio it was the best quarter in DSM’s history. Our outstanding performance in the quarter reflects very good volumes across our businesses combined with a continued disciplined focus on pricing and costs.
“DSM has emerged from the recession as a stronger company and is now reaping the benefits, evidenced by robust results and a very strong balance sheet. DSM is staying the course – fully committed to customers, innovation and sustainability – and continues its transformation towards a life sciences and materials sciences company.
“DSM remains vigilant about the broader macroeconomic developments. Based on the current positive business environment, we expect 2010 to be a strong year for DSM.”
Source: DSM
See also
Latest news
| |